These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 7955179)
21. Fibrin D-dimer, tissue plasminogen activator, plasminogen activator inhibitor, and the risk of major ischaemic heart disease in the Caerphilly Study. Lowe GD; Yarnell JW; Sweetnam PM; Rumley A; Thomas HF; Elwood PC Thromb Haemost; 1998 Jan; 79(1):129-33. PubMed ID: 9459337 [TBL] [Abstract][Full Text] [Related]
22. Prediction of Recurrent Events by D-Dimer and Inflammatory Markers in Patients with Normal Cardiac Troponin I (PREDICT) Study. Menown IB; Mathew TP; Gracey HM; Nesbitt GS; Murray P; Young IS; Adgey AA; Am Heart J; 2003 Jun; 145(6):986-92. PubMed ID: 12796753 [TBL] [Abstract][Full Text] [Related]
23. Plasma soluble fibrin monomer complex as a marker of coronary thrombotic events in patients with acute myocardial infarction. Ieko M; Naito S; Yoshida M; Kanazawa K; Mizukami K; Sato H; Yui T; Nakabayashi T; Hirabayashi T; Oguma Y Tohoku J Exp Med; 2009 Sep; 219(1):25-31. PubMed ID: 19713681 [TBL] [Abstract][Full Text] [Related]
24. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Ridker PM; Glynn RJ; Hennekens CH Circulation; 1998 May; 97(20):2007-11. PubMed ID: 9610529 [TBL] [Abstract][Full Text] [Related]
25. Plasma fibrin D-dimer levels and risk of stable coronary artery disease: results of a large case-control study. Koenig W; Rothenbacher D; Hoffmeister A; Griesshammer M; Brenner H Arterioscler Thromb Vasc Biol; 2001 Oct; 21(10):1701-5. PubMed ID: 11597948 [TBL] [Abstract][Full Text] [Related]
26. Do plasma biomarkers of coagulation and fibrinolysis differ between patients who have experienced an acute myocardial infarction versus stable exertional angina? Itakura H; Sobel BE; Boothroyd D; Leung LL; Iribarren C; Go AS; Fortmann SP; Quertermous T; Hlatky MA; Am Heart J; 2007 Dec; 154(6):1059-64. PubMed ID: 18035075 [TBL] [Abstract][Full Text] [Related]
27. The utility of coagulation activity for prediction of risk of mortality and cardiovascular events in guideline-treated myocardial infarction patients. Christersson C; Lindahl B; Berglund L; Siegbahn A; Oldgren J Ups J Med Sci; 2017 Nov; 122(4):224-233. PubMed ID: 29299952 [TBL] [Abstract][Full Text] [Related]
28. Homocysteine and risk of cardiovascular disease among postmenopausal women. Ridker PM; Manson JE; Buring JE; Shih J; Matias M; Hennekens CH JAMA; 1999 May; 281(19):1817-21. PubMed ID: 10340369 [TBL] [Abstract][Full Text] [Related]
30. Correlation between D-dimer levels and coronary artery reperfusion in acute myocardial infarction patients after thrombolytic treatment. Cakar MA; Gunduz H; Varim C; Ozdemir F; Vatan MB; Akdemir R Blood Coagul Fibrinolysis; 2013 Sep; 24(6):608-12. PubMed ID: 23917585 [TBL] [Abstract][Full Text] [Related]
31. A prospective study of lipoprotein(a) and the risk of myocardial infarction. Ridker PM; Hennekens CH; Stampfer MJ JAMA; 1993 Nov; 270(18):2195-9. PubMed ID: 8411602 [TBL] [Abstract][Full Text] [Related]
32. [Changes in coagulation and fibrinolysis in the patients with coronary heart disease in acute period and effect of drug intervention]. Jia XQ; Dong CM; Qin J; Zhang L Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Apr; 24(4):225-8. PubMed ID: 22464576 [TBL] [Abstract][Full Text] [Related]
33. Fibrin D-dimer, tissue-type plasminogen activator, von Willebrand factor, and risk of incident stroke in older men. Wannamethee SG; Whincup PH; Lennon L; Rumley A; Lowe GD Stroke; 2012 May; 43(5):1206-11. PubMed ID: 22382157 [TBL] [Abstract][Full Text] [Related]
34. Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study. Smith FB; Lee AJ; Fowkes FG; Price JF; Rumley A; Lowe GD Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3321-5. PubMed ID: 9409328 [TBL] [Abstract][Full Text] [Related]
35. High D-dimer levels predict cardiovascular events in patients with chronic atrial fibrillation during oral anticoagulant therapy. Vene N; Mavri A; Kosmelj K; Stegnar M Thromb Haemost; 2003 Dec; 90(6):1163-72. PubMed ID: 14652652 [TBL] [Abstract][Full Text] [Related]
36. Late activation of the fibrinolytic system in myocardial infarction treated with thrombolytic therapy. Influence of the coronary anatomical substrate. Salvioni A; Perego GB; Marenzi G; Lauri G; Giraldi F; Grazi S; Guazzi MD Eur Heart J; 1996 Feb; 17(2):230-6. PubMed ID: 8732376 [TBL] [Abstract][Full Text] [Related]
37. Baseline fibrinolytic state and the risk of future venous thrombosis. A prospective study of endogenous tissue-type plasminogen activator and plasminogen activator inhibitor. Ridker PM; Vaughan DE; Stampfer MJ; Manson JE; Shen C; Newcomer LM; Goldhaber SZ; Hennekens CH Circulation; 1992 May; 85(5):1822-7. PubMed ID: 1572039 [TBL] [Abstract][Full Text] [Related]
39. [Evolution of fibrinolysis status with D-dimer level and the rate of plasminogen activator inhibitor type-1/D-dimer in acute coronary syndrome patients complicated with impaired glucose tolerance]. Wu WD; Xu YH; Tan PY Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Aug; 15(8):472-5. PubMed ID: 12919647 [TBL] [Abstract][Full Text] [Related]